Breakdown | ||||
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
73.13K | 11.46M | 9.26M | 4.32M | 1.45M | Gross Profit |
-1.79M | -7.87M | -5.94M | -2.22M | -1.02M | EBIT |
-10.34M | -15.44M | -10.79M | -7.95M | -2.63M | EBITDA |
-8.53M | -13.86M | -10.06M | -7.73M | -2.59M | Net Income Common Stockholders |
-13.25M | -14.66M | -10.79M | -7.53M | -1.86M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.45M | 5.87M | 19.47M | 12.98M | 4.43M | Total Assets |
10.78M | 15.40M | 29.58M | 17.49M | 5.25M | Total Debt |
1.86M | 2.71M | 3.16M | 2.14M | 515.50K | Net Debt |
-589.95K | -3.16M | -16.31M | -10.83M | -3.92M | Total Liabilities |
3.53M | 5.29M | 5.60M | 3.37M | 873.04K | Stockholders Equity |
7.25M | 10.11M | 23.98M | 14.11M | 4.38M |
Cash Flow | Free Cash Flow | |||
-9.18M | -13.31M | -12.48M | -6.05M | -2.04M | Operating Cash Flow |
-8.55M | -11.87M | -10.17M | -5.71M | -1.99M | Investing Cash Flow |
-4.99M | -1.43M | -2.42M | -244.22K | -147.97K | Financing Cash Flow |
10.15M | -319.08K | 19.08M | 14.50M | 3.29M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | $683.96M | 13.97 | 4.68% | 6.79% | 14.72% | -42.17% | |
65 Neutral | €1.67B | 48.84 | 3.35% | 1.97% | 4.28% | ― | |
65 Neutral | $8.84B | 14.90 | 4.69% | 203.33% | 3.49% | -1.84% | |
55 Neutral | €13.54M | ― | -130.28% | ― | -69.28% | 38.42% | |
52 Neutral | $638.06M | 354.33 | 0.34% | ― | 64.18% | ― | |
51 Neutral | AU$846.53M | 25.13 | -0.01% | ― | 15.11% | ― | |
32 Underperform | AU$6.41M | ― | ― | 7.02% | -44.64% |
Wide Open Agriculture Ltd has announced the quotation of 110,869,565 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of May 15, 2025. This move is part of a previously announced transaction, potentially impacting the company’s market presence and offering stakeholders an opportunity to engage with its growth strategy.
Wide Open Agriculture Ltd. has announced a successful capital raising of $2.6 million through a placement, with plans to raise an additional $500,000 via a Share Purchase Plan. The funds will be utilized to accelerate the company’s market expansion, particularly targeting the Chinese market, and to further commercialize its lupin protein isolate, which has already seen initial global sales.
Wide Open Agriculture Ltd has announced a new offtake and distribution agreement with Univar Solutions China, aiming to establish a commercial market for its lupin-based products in China. While the agreement currently has no immediate financial impact, it involves WOA assisting Univar in market strategy and initial marketing activities, with a commitment from Univar to purchase a minimum of 50 tonnes of product within the first year following a six-month market preparation period.
Wide Open Agriculture Ltd has requested a trading halt on its securities pending an announcement regarding an offtake and distribution agreement. This move is intended to provide clarity on the terms of the agreement and is expected to impact the company’s market operations once the announcement is made.
Wide Open Agriculture Ltd. has entered into an exclusive marketing and distribution agreement with Univar Solutions China for its lupin protein products in mainland China. This partnership is a strategic move to enhance WOA’s presence in the Chinese market, leveraging Univar’s extensive distribution network and expertise in the food and nutrition sector. The agreement is expected to boost WOA’s market strategy in the premium ingredients sector, supporting sustainable and innovative food solutions in China.
Wide Open Agriculture Ltd announced the cessation of certain securities, specifically the lapse of 324,296 performance rights and the expiry of 2,952,064 options. This cessation reflects the company’s ongoing management of its capital structure, potentially impacting investor perceptions and the company’s market positioning.
Wide Open Agriculture Ltd has reported significant progress in its operations for the quarter ending March 31, 2025. The company has successfully expanded its sales pipeline across multiple countries, with lupin protein isolate now approved for sale in China, a market valued at US$4.2 billion. The approval opens up substantial opportunities for growth, particularly given the protein’s non-GMO status and health benefits. The company also received a repeat order from Latin America, highlighting growing demand. Additionally, Wide Open Agriculture is developing new lupin-based products, such as tofu and protein bases for dips and spreads, and exploring new markets for lupin co-products. The appointment of a new CFO and a focus on cost control and operational efficiency further position the company for future growth.
Wide Open Agriculture Ltd has received a tax rebate of $1,277,758 from the Australian Government’s R&D tax incentive scheme for its research and development activities in the 2023-24 financial year. This rebate will support the company’s operational expenses related to the commercialization of its lupin protein and strengthen its balance sheet by repaying a $500,000 R&D loan. The funding will also aid in pursuing strategic objectives, such as entering the South East Asian market for lupin protein, potentially enhancing the company’s industry positioning and stakeholder value.
Wide Open Agriculture Ltd has released a presentation highlighting the significant health benefits of lupin protein, which can positively impact cardiovascular disease, hypertension, diabetes, and other health issues. This initiative aims to engage food and beverage companies worldwide in discussions about incorporating lupin protein into their products, potentially enhancing WOA’s market position and consumer outreach.
Wide Open Agriculture Ltd. has announced a change in the interests of a substantial holder, Liam Cornelius, who has reduced his voting power from 19.92% to 14.28% following an on-market sale of 2,500,000 shares. This adjustment in shareholding could impact the company’s governance dynamics and influence within the market, potentially affecting stakeholder confidence and future strategic decisions.
Wide Open Agriculture Ltd has announced the release of a product application presentation at the Food and Ingredients China 2025 conference in Shanghai, marking its strategic move to explore new opportunities in China and Southeast Asia. This initiative, presented by key company figures in both English and Chinese, aims to engage potential distributors and global B2B end users, potentially enhancing the company’s market presence and stakeholder engagement in the region.
Wide Open Agriculture Ltd. has responded to a price query from the Australian Securities Exchange regarding the recent fluctuation in its securities’ trading price and volume. The company confirmed it is unaware of any undisclosed information that could explain the trading activity and assured compliance with ASX Listing Rules, emphasizing transparency and adherence to regulatory standards.
Wide Open Agriculture Ltd. has secured new sales for its lupin protein isolates across Europe, Latin America, and Australia, marking a significant step in the commercialization of its products. These sales, though not financially material, demonstrate the global potential of WOA’s lupin proteins, which are gaining traction for their taste, functionality, and sustainability credentials. The company’s strategy to showcase the potential of its lupin proteins is supported by strong customer endorsements and aligns with cultural consumption patterns in Europe and Latin America, providing a foundation for market development across five continents.
Wide Open Agriculture Ltd. has announced a strategic business review focusing on its proprietary lupin protein IP, aiming to leverage opportunities in the South East Asian market. The company plans to consolidate operations in Australia, evaluate options for its German facility, and transition to a capital-light production model. With regulatory approval to supply lupin protein isolate to China and a growing sales pipeline, the company is poised to expand its market presence. Cost-cutting measures and strategic funding initiatives, including an $80,000 grant, are expected to support these objectives.
Wide Open Agriculture Ltd. reported a significant increase in revenue from ordinary activities for the half-year ending December 31, 2024, despite a net loss attributable to members. The increase in revenue did not translate to profitability due to the absence of a Research & Development Tax Offset recorded in the previous period, highlighting challenges in maintaining financial stability and raising concerns about the company’s ongoing operations.